|
|
|
Corporate Profile:
VentiRx Pharmaceuticals
| Summary: |
| VentiRx Pharmaceuticals is focused on Toll-like receptor 8 (TLR8) therapeutics for the treatment of cancer, respiratory, and autoimmune diseases. |
| Address (HQ): |
1191 Second Avenue
Suite 1105
Seattle, WA 98101 |
| Phone
#'s (HQ): |
| Main |
(206) 689-2259 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
